Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical and biotechnology sector [5][39]. Core Insights - The pharmaceutical sector has shown resilience, outperforming the overall market, with traditional Chinese medicine leading the gains [1][28]. - Roche's oral BTK inhibitor Fenebrutinib has demonstrated non-inferiority to Ocrelizumab in a Phase III trial for primary progressive multiple sclerosis (PPMS), marking a significant advancement in treatment options for this condition [2][11]. - The global market for multiple sclerosis (MS) treatment exceeds $20 billion, with Roche's Ocrevus projected to generate CHF 7 billion in sales by 2025, indicating substantial unmet needs in the PPMS segment [3][25]. Summary by Sections Market Performance - The overall A-share market declined by 1.3%, while the biopharmaceutical sector increased by 0.1%, indicating a stronger performance relative to the market [1][28]. - Specific segments within the biopharmaceutical sector showed varied performance, with traditional Chinese medicine rising by 2.6% and medical services increasing by 1.3% [1][28]. Clinical Data and Drug Development - Roche's Fenebrutinib trial included 985 PPMS patients and achieved its primary endpoint, showing a 12% reduction in disease progression risk compared to Ocrelizumab [2][11]. - The trial results suggest potential benefits for upper limb function, reinforcing the viability of BTK inhibitors in MS treatment [3][25]. Company Earnings Forecast and Investment Recommendations - Key companies in the sector, such as Mindray Medical, WuXi AppTec, and Aier Eye Hospital, are rated as "Outperform" with projected earnings growth over the next few years [4][39]. - Mindray Medical is highlighted for its strong R&D and international expansion, while WuXi AppTec is recognized for its comprehensive drug development services [39]. Valuation Metrics - The TTM price-to-earnings ratio for the pharmaceutical and biotechnology sector stands at 37.31x, compared to the overall A-share market at 21.98x, indicating a premium valuation for the sector [35][36]. - Within the sector, chemical pharmaceuticals and biological products have higher valuations at 45.18x and 46.09x, respectively [35].

Market Overview - The textile and apparel sector in A-shares has outperformed the broader market since February, with the textile manufacturing segment rising by 3.6% compared to a 2.0% increase in brand apparel [11] - The Hong Kong textile and apparel index has increased by 4.4% since February, also outperforming the market [11] - Notable companies with significant stock price increases include Under Armour (14.9%), Amer Sports (9.7%), and Jiangnan Buyi (9.6%) [11] Brand Apparel Insights - In December, the year-on-year growth of clothing retail sales was 0.6%, with a slowdown in growth compared to previous months [5] - January saw a 32.5% decline in operating income for sports retailer BaoSheng International, indicating pressure on overall clothing retail [5] - E-commerce sales rebounded in January, driven by promotional activities and pre-Spring Festival purchasing [5] - Outdoor apparel categories showed strong growth, with year-on-year increases of 17% for outdoor clothing and 5% for sports apparel [5] - Leading brands in growth include Lululemon (47%), Descente (29%), and Adidas (16%) in the sports apparel segment [5] Textile Manufacturing Insights - Vietnam's textile exports increased by 8.3% year-on-year in January, while footwear exports rose by 7.8% [5] - The macroeconomic environment shows mixed signals, with PMI in Indonesia and India rising, while Vietnam's PMI decreased slightly but remains above 50 [5] - Wool prices have increased by 15.3% since the beginning of the year, with a year-on-year increase of 54.9% as of February 5 [5] - Taiwanese companies are experiencing short-term revenue pressure but show optimistic growth prospects, particularly with the upcoming 2026 World Cup driving demand for football-related products [5] Company Performance Forecasts - Several companies in the textile and apparel sector, including Bailong Dongfang and Tianhong International, are expected to see net profit growth of over 40% [2] - Key drivers for profit growth include increased order volumes, improved capacity utilization, and lower raw material costs [2] - Le Xin Outdoor, a leading global fishing gear manufacturer, is projected to maintain a 23.1% market share in 2024 [2] Investment Recommendations - The report suggests focusing on brands that are likely to benefit from the Spring Festival sales surge and the performance elasticity of upstream suppliers [5] - High-end consumer recovery is anticipated, particularly in the light luxury sports and outdoor segments [5] - Companies such as Anta Sports, Li Ning, and Xtep International are recommended for their strong positioning in the market [5] - The report highlights the importance of the upcoming 2026 World Cup in driving orders for sports apparel and footwear [5]

Investment Rating - The report rates the silver economy industry as "Outperform" compared to the market [1]. Core Insights - The demand for elderly care products is increasing due to the rising proportion of individuals aged 65 and above, as well as the growing number of elderly living alone and those with disabilities. AI technology is enhancing product capabilities and expanding market demand [1][12]. - The report categorizes elderly care durable goods into three main areas: daily living assistance, emotional companionship, and health safety [21]. Summary by Sections Elderly Care Durable Goods Overview - The report highlights the increasing demand for smart elderly care devices, including nursing robots, companion robots, home care equipment, and AI mattresses, driven by the aging population and technological advancements [1][12]. Home Care Equipment - AI is enhancing the functionality of home care devices, which are crucial for monitoring elderly individuals, especially to prevent falls. The market for independent care devices is projected to reach 14 million units by 2030, with a compound annual growth rate of 16% [2][32]. - Leading companies in this sector include Yingzi Network, which offers a comprehensive home care solution through its "Yingzi Elderly Smart Body" product [2][19]. Elderly Care Robots - The market for nursing robots is expected to reach a scale of hundreds of billions, with significant growth driven by policy support and the introduction of new products across various segments [3][43]. - Key players include Ousheng Electric, which specializes in nursing robots, and Rongtai Health, known for its massage therapy robots [3][42]. Smart Mattresses - Smart mattresses are identified as a potential growth category due to their low penetration rate and high demand. The domestic mattress market is expected to reach approximately 65.9 billion RMB by 2024, with smart mattresses projected to increase in market share [4][12]. - Leading companies in this segment include Xilinmen and Mousse Co., which are developing AI-driven sleep solutions [4][50]. Policy Support - The report outlines various government policies aimed at promoting the integration of technology and elderly care, including subsidies for home modifications and the development of smart elderly care products [24][26]. - The Ministry of Civil Affairs and other departments have issued measures to encourage the development of elderly care robots and related technologies [26][27]. Market Demand Projections - The report estimates that by 2030, the number of elderly individuals requiring care will significantly increase, leading to a robust demand for nursing robots and related technologies [45][43]. - The total market demand for elderly care robots in China and abroad is projected to exceed 200 billion RMB [45][43].

Market Overview - The textile and apparel sector in A-shares has outperformed the broader market since February, with the textile manufacturing index rising by 3.6% and the brand apparel index by 2.0% [11] - The Hong Kong textile and apparel index has increased by 4.4% since February, also outperforming the market [11] - Notable companies with significant stock price increases include Under Armour (14.9%), Amer Sports (9.7%), and Jiangnan Buyi (9.6%) [11] Brand Apparel Insights - In December, the year-on-year growth of clothing retail sales was 0.6%, with a slowdown in growth compared to previous months [5] - January saw a 32.5% decline in operating income for sports retailer BaoSheng International, attributed to the timing of the Spring Festival [5] - E-commerce sales in January rebounded, driven by promotional activities and pre-holiday purchases, with outdoor apparel leading growth at 17% year-on-year [5] - Key brands showing strong growth in the sports apparel category include Lululemon (47%), Descente (29%), and Adidas (16%) [5] Textile Manufacturing Insights - Vietnam's textile exports increased by 8.3% year-on-year in January, while footwear exports rose by 7.8% [5] - The macroeconomic environment shows mixed signals, with PMI in Indonesia and India rising, while Vietnam's PMI slightly decreased but remains above 50 [5] - Wool prices have increased by 15.3% year-to-date, with a year-on-year increase of 54.9% as of February 5 [5] - Companies like RuHong and GuangYue are experiencing revenue growth due to order continuity and optimized production structures [5] Annual Performance Forecasts - Several companies in the textile and apparel sector, including Bailong Dongfang and Tianhong International, have issued profit forecasts indicating over 40% growth in net profit [2] - Factors contributing to this growth include full order books, improved capacity utilization, and declining raw material costs [2] Investment Recommendations - The report suggests focusing on brands that are likely to benefit from the Spring Festival sales surge and the performance elasticity of upstream suppliers [5] - High-end consumer recovery is anticipated, particularly in the light luxury sports and outdoor segments [5] - Key recommendations include Anta Sports, Li Ning, and Xtep International, which are well-positioned to capture market growth [5] Key Company Earnings Forecasts - Anta Sports is rated "Outperform" with an expected EPS of 4.72 for 2025 and 4.98 for 2026 [6] - Li Ning is also rated "Outperform" with an expected EPS of 1.01 for 2025 and 1.08 for 2026 [6] - Other companies such as Xtep International and 361 Degrees are similarly rated "Outperform" with positive earnings forecasts [6]

Investment Rating - The report gives an "Outperform" rating for the company [5][3] Core Views - The company is expected to see profit recovery in the first three quarters of 2025, with revenue reaching 30.24 billion yuan, a year-on-year increase of 4.94%, and a net profit of 999.2 million yuan, up 5.15% year-on-year [1][26] - The management team has been rejuvenated with a core group of individuals born in the 1980s, which is expected to enhance governance and operational efficiency [1][22] - The company is strategically positioned in military aircraft and military trade, with a solid product matrix for military transport aircraft and ongoing development of special aircraft based on the Y-20 platform [2][41] - In the civil aviation sector, the company is set to benefit from the growth of the C919 aircraft and is actively engaging in the low-altitude economy, which is projected to be a trillion-yuan market [2][57] Summary by Sections Financial Performance - In the first three quarters of 2025, the company achieved a revenue of 30.24 billion yuan, with a significant quarterly revenue increase of 27.51% in Q3 [1][26] - The net profit margin reached 3.28%, marking a recent high for the company [1][26] - The company’s revenue and profit are expected to continue growing, with projected net profits of 1.17 billion yuan, 1.34 billion yuan, and 1.52 billion yuan for 2025, 2026, and 2027 respectively [3][74] Business Segments - The military segment is solid, with the company being the sole producer of strategic transport aircraft in China, and the Y-20 has achieved mass production capabilities [2][41] - The civil aviation segment is expected to benefit from the C919 aircraft, with a projected market size of several hundred billion yuan over the next 20 years [2][57] - The company is also expanding into the low-altitude economy, with products like the HH-200 unmanned transport system, which is in the process of obtaining airworthiness certification [2][65] Management and Governance - The management team has undergone significant changes, with a focus on younger leadership, which is expected to improve decision-making and operational stability [1][22] - The new management structure includes several individuals with extensive experience in the aviation industry, indicating a strategic shift towards expertise-driven leadership [22][25] Market Position and Competitive Landscape - The company has established a strong foothold in both military and civil aviation markets, with a focus on high-performance military aircraft and a comprehensive product line for civil aviation [19][41] - The company’s operational efficiency is reflected in its low expense ratio, which is expected to support future profitability [38][30]

Investment Rating - The investment rating for Tianli International Holdings (01773.HK) is "Outperform the Market" (maintained) [2][16]. Core Views - The company is strategically expanding its enrollment of transfer students to counteract the previous slowdown in enrollment growth, with a target of approximately 7,000 transfer students for the fiscal year 2026, which is expected to increase the total number of students served by about 14% year-on-year [3][5]. - The AI education products are showing sustained effectiveness, accelerating revenue conversion. The AI Sprint Camp has reached 1,934 students as of January 26, 2026, with expectations to exceed 4,000 students for the year, projecting revenues of 0.88 billion, 1.54 billion, and 2.31 billion for FY2026, FY2027, and FY2028 respectively [3][8][11]. - The company forecasts revenues of 39.15 billion, 42.25 billion, and 44.99 billion for FY2026, FY2027, and FY2028, with corresponding growth rates of 9.1%, 7.9%, and 6.5%. Adjusted net profits are projected to be 7.41 billion, 8.21 billion, and 9.01 billion for the same periods, with growth rates of 11.5%, 10.9%, and 9.7% [3][16]. Summary by Sections Enrollment Strategy - The company is actively adjusting its enrollment strategy to address the short-term negative impact on enrollment growth. As of January 25, 2026, 3,603 transfer students have been enrolled, with a projected total of 14.8 million students served in FY2026, reflecting a year-on-year increase of approximately 14% [3][5]. - The strategy includes a slight relaxation of enrollment standards to increase student reserves while maintaining teaching quality [7]. AI Education Business - The AI Sprint Camp business is accelerating its commercialization, with expected revenue conversion of 0.88 billion for FY2026. The program has shown significant improvement in student performance, with a notable increase in the number of students covered [8][10]. - The AI system, developed by the company's subsidiary, aims to enhance educational outcomes, particularly for students who are lagging behind [10]. Share Buyback and Investor Confidence - The company announced a share buyback plan, intending to repurchase up to 200 million HKD worth of shares in the open market, which is expected to enhance investor confidence [3][12].

证券研究报告 | 2026年02月12日 天立国际控股（01773.HK） 招生短期利空出清，AI 教育加速转化收入 事项： 2026 年 1 月 28 日，天立国际控股公司召开 2026 年股东周年大会暨 AI 专题反向路演活动，并在线上进行 公开直播。会上，公司通过股东大会、管理层交流、AI 产品体验、AI 示范校参观等多环节，向市场公开、 全面展示集团学历学校招生情况，以及"AI+教育"领域的深度布局、领先实践与未来蓝图。 同日，公司发布意向回购公告。董事会决定在公告日期至下届股东周年大会结束（或股东撤销/更改购回 授权），期间，根据市况及购回授权，动用最高 2 亿港元在公开市场不时购回股份；每股购回价不高于紧 接每次购回前五个交易日平均收市价的 5%。 国信社服观点：1）公司为调整此前"提升生源门槛"导致的招生增速下滑，战略性积极扩招转校生补充 生源，截至 2026 年 1 月 25 日，集团已完成转校生招生 3603 人，预计全年有望达成 7000 人，带动 26 财 年公司全年服务学生人数同比自 8%提升至约 14%； 2）AI 教育产品效果得到持续验证，加速转化收入。截至 2026 年 1 月 ...

Macro and Strategy - The macro review highlights a significant increase in PPI month-on-month, with January 2026 CPI showing a year-on-year increase of 0.2% and PPI down by 1.4% compared to the previous year [5][6] - The Hang Seng Technology Index has faced a downturn, failing to experience the expected post-Lunar New Year rally, with a notable shift in investment from high-growth tech stocks to dividend-paying assets [5][6] - The report discusses the performance of various asset classes, indicating a decline in equity indices and mixed results in commodity prices, with WTI crude oil rising by 2.75% [5][6] Industry and Company - The internet industry report emphasizes the growth potential of AI applications, with major companies like SpaceX and Meta making significant advancements in AI technology [13][14] - The pharmaceutical industry report suggests a focus on undervalued sectors, particularly in medical services and consumer-related segments, anticipating a recovery in 2026 [15][16] - China Uranium Industry (001280.SZ) is highlighted for its strong position in the natural uranium market, with a projected production of 3,955 tons in 2024, accounting for 6.4% of global output [17][18] - Bilibili (09626.HK) is expected to benefit from increased advertising revenue in 2026 due to the gaming industry's growth and the rise of AI applications [19][20] - Semiconductor company SMIC (00981.HK) reported a revenue of $2.489 billion in Q4 2025, exceeding guidance, with expectations for growth in 2026 to surpass industry averages [21][22] - Lianchuang Optoelectronics (600363.SH) is focusing on high-temperature superconductors and laser technology, with a projected net profit growth of 19.4% in 2025 [25][26]

证券研究报告 | 2026年02月10日 2026年02月11日 中芯国际（00981.HK） 优于大市 四季度收入超指引上限，预计 2026 年增速高于可比同业均值 4Q25 营收超指引上限，预计 2026 年收入增幅高于可比同业均值。公司 4Q25 实现销售收入 24.89 亿美元（YoY +12.8%，QoQ +4.5%），高于指引(QoQ 0%-2%) 上限，续创季度收入新高，晶圆收入占总收入的 92.4%；毛利率因折旧增加 降至 19.2%(YoY -3.4pct，QoQ -2.7pct)，符合指引；归母净利润为 1.73 亿 美元(YoY +60.7%，QoQ -10.0%)。预计 1Q26 营收环比持平，毛利率为 18%-20%， 2026 年全年收入增幅高于可比同业平均值。 四季度产能利用率环比基本持平，预计 2026 年资本开支与 2025 年持平。公 司 4Q25 付运折合 8 英寸晶圆 251 万片(YoY +26.3%，QoQ +0.6%)，产能利用 率为 95.7%(YoY +10.2pct，QoQ -0.1pct)。在晶圆收入中 12 英寸晶圆贡献 77.2%，8 英寸晶圆贡献 2 ...

Investment Rating - The report initiates coverage with an "Outperform" rating for the company [3][5]. Core Views - The company has achieved a significant improvement in its financial performance, with a notable increase in net profit and revenue in the first three quarters of 2025, indicating a turning point in its business trajectory [1][21]. - The focus on "Laser + High-Temperature Superconductors" is optimizing the company's industrial structure, leading to enhanced profitability and growth potential in high-value sectors [2][14]. - The company is well-positioned to benefit from the growing demand in the laser and high-temperature superconducting markets, particularly in commercial aerospace and defense applications [23][40]. Financial Performance Summary - For the first three quarters of 2025, the company reported a revenue of 2.503 billion yuan, a year-on-year increase of 2.83%, and a net profit of 400 million yuan, up 19.40% year-on-year [1][8]. - The third quarter of 2025 saw a revenue of 856 million yuan, down 3.49% year-on-year but up 1.06% quarter-on-quarter, with a net profit of 137 million yuan, reflecting a 28.04% year-on-year increase [1][21]. - The gross margin for the first three quarters of 2025 was 19.73%, an increase of 3.84 percentage points year-on-year, while the net margin was 16.48%, also reflecting a significant improvement [8][25]. Earnings Forecast and Financial Metrics - The company is projected to achieve net profits of 477 million yuan, 584 million yuan, and 661 million yuan for 2025, 2026, and 2027 respectively, indicating growth rates of 97.9%, 22.3%, and 13.2% [4][3]. - Earnings per share (EPS) are expected to be 1.05 yuan, 1.28 yuan, and 1.45 yuan for the same years, with dynamic price-to-earnings (PE) ratios of 60, 49, and 44 [4][3]. - The report estimates the reasonable stock value to be between 72.4 and 75.1 yuan, suggesting a premium of 14.6% to 18.9% over the current stock price of 63.17 yuan [3][5]. Industry Positioning and Strategic Focus - The company is strategically positioned in the laser and high-temperature superconducting sectors, with a complete industrial chain from core components to system integration [40][47]. - The focus on high-temperature superconductors is expected to drive significant growth, particularly in applications related to controlled nuclear fusion and advanced manufacturing technologies [52][59]. - The company is also exploring opportunities in the commercial aerospace sector, leveraging its technological advancements in electromagnetic launch systems [66][74].